Patient acceptability of genotypic testing for hemochromatosis in primary care

Genetics in Medicine

Volumn 7, Issue 8, 2005, Pages 557-563

  Anderson, Roger T ^a   Press, Nancy ^b   Tucker, Diane C ^c   Snively, Beverly M ^a   Wenzel, Lari ^d   Ellis, Shellie D ^a   Hall, Mark A ^a   Walker, Ann P ^d   Thomson, Elizabeth J ^e   Lewis Jack, Ometha ^f   Acton, Ronald T ^g  

^a WAKE FOREST SCHOOL OF MEDICINE   (United States)

^b CENTER FOR HEALTH RESEARCH   (United States)

^c UNIVERSITY OF ALABAMA AT BIRMINGHAM   (United States)

^d UNIVERSITY OF CALIFORNIA   (United States)

^e NATIONAL HUMAN GENOME RESEARCH INSTITUTE   (United States)

^f HOWARD UNIVERSITY   (United States)

^g University of Alabama at Birmingham   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AFRICAN AMERICAN; AGE; AGED; ARTICLE; CAUCASIAN; DOCTOR PATIENT RELATION; FEMALE; GENOTYPE; HEALTH STATUS; HEMOCHROMATOSIS; HUMAN; IRON BLOOD LEVEL; IRON OVERLOAD; MALE; MEDICAL PRACTICE; PATIENT ATTITUDE; PATIENT EDUCATION; PHENOTYPE; PRIMARY MEDICAL CARE; RACE DIFFERENCE; RATING SCALE; REFUSAL TO PARTICIPATE; RISK; SELF EVALUATION; SEX ROLE;

ADULT; AFRICAN AMERICANS; AGED; CONFIDENTIALITY; EUROPEAN CONTINENTAL ANCESTRY GROUP; FEMALE; GENETIC SCREENING; GENOTYPE; HEMOCHROMATOSIS; HUMANS; IRON; MALE; MIDDLE AGED; PATIENT ACCEPTANCE OF HEALTH CARE; PATIENT EDUCATION; PRIMARY HEALTH CARE;

EID: 27644461346     PISSN: 10983600     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.GIM.0000177531.53338.65     Document Type: Article

References (40)

1. Guttmacher AE, Collins FS. Welcome to the genomic era. N Engl J Med 2003;349:996-8.
2. Collins FS. A brief primer on genetic testing. Paper presented World Economic Forum, Jan 24. 2003 Porto Alegre Brazil. Available at: www.http//nhgri.nih.gov/ 10506784. Accessed January 2005.
3. Boyle P. Introduction to Genetic Grammar: Health, Illness, and the Human Genome Project. Hastings Center Report 1992;22:S1.
4. Hubbard R, Wald E. Exploding the Gene Myth: How Genetic information Is Produced and Manipulated by Scientists, Physicians, Employers, Insurance Companies, Educators, and Law Enforcers. 1993;206 p. Boston: Beacon Press.
5. Wertz DC, Fletcher JC, eds. (1989) Ethics and Hum Genet: A Cross-cultural Perspective. 536 p. Berlin and New York: Springer-Verlag.
6. Bish A, Sutton S, Jacobs C, Levine S, Ramirez A, Hodgson S. No news is (not necessarily) good news: impact of preliminary results for BRCA1 mutation searches. Genet Med 2002;4:353-358.
7. Broadstock M, Michie S, Marteau T. Psychological consequences of predictive genetic testing: a systematic review. Eur J Hum Genet 2000;8:731-8.
8. Coyne JC, Kruus L, Racioppo M, Calzone KA, Armstrong K. What do ratings of cancer-specific distress mean among women with high risk of breast and ovarian cancer? Am J Med Genet 2003;116A:222-228.
9. Horowitz MJ, Field NP, Zanko A, Donnelly EF, Epstein C, Longo F. Psychological impact of news of genetic risk for Huntington disease. Am J Med Genet 2001;103: 88-92.
10. Bonadona V, Saltel P, Desseigne F, et al. Cancer patients who experienced diagnostic genetic testing for cancer susceptibility: reactions and behavior after the disclosure of a positive test result. Cancer Epidemiol Biomarkers Prev 2002;11:97-104.
11. Lodder L, Frets PG, Trijsburg RW, et al. Psychological impact of receiving a BRCA1/BRCA2 test result. Am J Med Gen 2001;98:15-24.
12. Dorval M, Patenaude AF, Schneider KA, et al. Anticipated versus actual emotional reactions to disclosure of results of genetic tests for cancer susceptibility: Findings from p53 and BRCA1 testing programs. J Clin Oncol 2000;18:2135-2142.
13. Decruyenaere M, Evers-Kiebooms G, Cloostermans T, et al. Psychological distress in the 5-year period after predictive testing for Huntington's Disease. Eur J Hum Genet 2003;11:30-38.
14. Gordon C, Walpole I, Zubrick SR, Bower C. Population Screening for cystic fibrosis: knowledge and emotional consequences 18 months later. Am J Med Genet 2003;120A:199-208.
15. van Maarle MC, Stouthard ME, Marang-van de Mheen PJ, Klazinga NS, Bonsel GH. How disturbing is it to be approached for a genetic cascade screening programme for familial hypercholesterolaemia? Psychological impact and screenees' views. Community Genet 2002;4:244-252.
16. Lerman C, Narod S, Schulman K, et al. BRCA1 testing in families with hereditary breast-ovarian cancer. JAMA 1996;275:1885-1892.
17. Lerman C, Croyle R. Psychological issues in genetic testing for breast cancer susceptibility. Arch Intern Med 1994;154:609-616.
18. Schwartz MD, Peshkin BN, Hughes C, Main D, Isaacs C, Lerman C. Impact of BRCA1/BRCA2 mutation testing on psychologic distress in a clinic-based sample. J Clin Oncol 2002;20:514-20.
19. Croyle RT, Smith KR, Botkin JR, Baty B, Nash I. Psychological responses to BRCA1 mutation testing: Preliminary findings. Health Psychol 1997;16:63-72.
20. Lerman C, Hughes C, Lemon SJ, et al. What you don't know can hurt you: Adverse psychological effects in members of BRCA1-linked and BRCA2-linked families who decline genetic testing. J Clin Oncol 1998;16:1650-1654.
21. Meiser B, Butow P, Friedlander M, et al. Psychological impact of genetic testing for women for high risk breast cancer families. Eur J Cancer 2002;38:2025-2031.
22. Di Prospero LS, Seminsky M, Honeyford J, et al. Psychological issues following a positive result of genetic testing for BRCA1 and BRCA2 mutations: findings from a focus group and needs-assessment survey. CMAJ 2001;164:1005-1009.
23. Bacon BR. Hemochromatosis: diagnosis and management. Gastroenterology 2001;120:718-725.
24. Barton JC, Acton RT. Population screening for hemochromatosis: has the time finally come? Curr Gastroenterol Rep 2000;2:18-26.
25. Dubois S, Kowdley KV. The importance of screening for hemochromatosis. Arch Intern Med 2003;163:2424-2426.
26. Niederau C, Fischer R, Purschel A, Stremmel W, Haussinger D, Strohmeyer G. Long-tern survival in patients with hereditary hemochromatosis. Gastroenterology 1996;110:1107-1119.
27. Motulsky AG, Beutler E. Population screening in hereditary hemochromatosis. Annu Rev Public Health 2000;21:65-79.
28. Feder JN, Gnirke A, Thomas W, et al. A novel MHC class I-like gene is mutated in patients with hereditary haemochromatosis. Nat Genet 1996;13:399-408.
29. Acton RT, Barton JC. Hereditary Hemochromatosis. In: Encyclopedia of Medical Genomics and Proteomics, Fuchs J, Podda M Eds, Marcel Dekker, Inc. New York, (In press, 2004).
30. Friedman LC, Webb JA, Richards CS, et al. Psychological impact of receiving negative BRCA1 mutation test results in Ashkenazim. Genet Med 1999;1:74-79.
31. Gason A, Aitken M, Metcalf S, Allen K, Delaycki M. Genetic susceptibility screening in schools: attitudeds of the school community towards hereditary haemochromatosis. Clin Genet 2004;67:166-174.
32. Corbie-Smith G, Thomas SB, Williams MV, Moody-Ayers S. Attitudes and beliefs of African Americans toward participation in medical research. J Gen Intern Med 1999;14:537-546.
33. McLaren CE, Barton JC, Adams PC, et al. Hemochromatosis and Iron Overload Screening (HEIRS) study design for an evaluation of 100,000 primary care-based adults. Am J Med Sci 2003;325:53-62.
34. Ware Jr. JE, Sherbourne CD. The MOS 36-item short-form health survey (SF-36). I. Conceptual framework and item selection. Med Care 1992;30:473-483.
35. McHorney CA, Ware Jr. JE, Lu JF, Sherbourne CD. The MOS 36-item Short-Form Health Survey (SF-36): III. Tests of data quality, scaling assumptions, and reliability across diverse patient groups. Med Care 1994;32:40-66.
36. White RM. Unraveling the Tuskegee Study of Untreated Syphilis. Arch Intern Med 2000;160:585-598.
37. White RM. Sociocultural Issues in Clinical Research: Unraveling the Tuskegee Syphilis Study. Arthritis & Rheumatism 2002;47:456-458.
38. Patch C, Roderick P, Rosenberg W. Genetic screening for Hemochromatosis is no less acceptable than biochemical screening. Am J Human Gent 2003;735:417.
39. Hicken B, Calhoun DC, Tucker DC. Genetic testing for hemochromatosis: Attitudes and acceptability among young and older adults. Genetic Testing 2003;7:235-239.
40. U.S. Census Bureau; Census 2000, Summary File 1 (SF 1) and Summary File 3 (SF 3); generated by Shellie Ellis; using American FactFinder; Available at: http:// factfinder.census.gov. Accessed May 2 2005.